Ann: Change of Director's Interest Notice-SRX.AX, page-31

Hi Mark - all good. The material aspect is most important as this is the only hook that is available from a regulatory point of view. Other than that it is an internal SRX process, and the Board need to be advised on any discontent with the actions of the CEO.

Of course reminding the Board of the regulatory aspects, may make them a little more interested in following up on the action?

As an aside, I know you have been keeping a SS on SRX. Have you performed a what if analysis of the various doses growth rates ? If so then I guess you have the ability to yield the current year's dose sales %, from the current SP? Is that something you would be prepared to share? My numbers come out at about 17%.